• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Proc Natl Acad Sci USA. Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput seque

Giuseppe

Emeritus
[Source: Proceedings of the National Academy of Sciences of the United States of America, full page: (LINK). Abstract, edited.]


Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing

David Skurnik<SUP>a</SUP>,<SUP>1</SUP>,<SUP>2</SUP>, Damien Roux<SUP>a</SUP>,<SUP>1</SUP>, Vincent Cattoir<SUP>b</SUP>,<SUP>c</SUP>,<SUP>3</SUP>, Olga Danilchanka<SUP>b</SUP>,<SUP>3</SUP>, Xi Lu<SUP>a</SUP>, Deborah R. Yoder-Himes<SUP>d</SUP>, Kook Han<SUP>b</SUP>, Thomas Guillard<SUP>a</SUP>, Deming Jiang<SUP>a</SUP>, Charlotte Gaultier<SUP>a</SUP>, Fran?ois Guerin<SUP>c</SUP>, Hugues Aschard<SUP>e</SUP>, Roland Leclercq<SUP>c</SUP>, John J. Mekalanos<SUP>b</SUP>, Stephen Lory<SUP>b</SUP>, and Gerald B. Pier<SUP>a</SUP>,<SUP>2</SUP>
<SUP></SUP>
Author Affiliations: <SUP>a</SUP>Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; <SUP>b</SUP>Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115; <SUP>c</SUP>?quipe Antibior?sistance 4655, Facult? de M?decine, Universit? de Caen Basse-Normandie, F-14032 Caen, France; <SUP>d</SUP>Department of Biology, University of Louisville, Louisville, KY 40202; and <SUP>e</SUP>Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115

Edited* by Frederick M. Ausubel, Harvard Medical School and Massachusetts General Hospital, Boston, MA, and approved October 11, 2013 (received for review December 11, 2012)


Significance

It is thought antibiotic resistance carries a fitness cost and reduces microbial virulence. Using high-throughput sequencing analysis of a transposon insertion bank in Pseudomonas aeruginosa, we found enhanced fitness for in vivo mucosal colonization and systemic spread of strains with transposon insertions in the oprD gene. This conferred resistance to carbapenem antibiotics as well as enhanced resistance to killing at acidic pH and by normal human serum along with increased cytotoxicity against murine macrophages. RNA-sequencing analysis revealed that oprD deficiency led to transcriptional changes in numerous genes that may contribute to the enhanced in vivo fitness observed. Thus, if carbapenem resistance develops during antibiotic therapy of P. aeruginosa infections, it may lead to enhanced fitness and virulence in infected hosts.


Abstract

An important question regarding the biologic implications of antibiotic-resistant microbes is how resistance impacts the organism?s overall fitness and virulence. Currently it is generally thought that antibiotic resistance carries a fitness cost and reduces virulence. For the human pathogen Pseudomonas aeruginosa, treatment with carbapenem antibiotics is a mainstay of therapy that can lead to the emergence of resistance, often through the loss of the carbapenem entry channel OprD. Transposon insertion-site sequencing was used to analyze the fitness of 300,000 mutants of P. aeruginosa strain PA14 in a mouse model for gut colonization and systemic dissemination after induction of neutropenia. Transposon insertions in the oprD gene led not only to carbapenem resistance but also to a dramatic increase in mucosal colonization and dissemination to the spleen. These findings were confirmed in vivo with different oprD mutants of PA14 as well as with related pairs of carbapenem-susceptible and -resistant clinical isolates. Compared with OprD<SUP>+</SUP> strains, those lacking OprD were more resistant to killing by acidic pH or normal human serum and had increased cytotoxicity against murine macrophages. RNA-sequencing analysis revealed that an oprD mutant showed dramatic changes in the transcription of genes that may contribute to the various phenotypic changes observed. The association between carbapenem resistance and enhanced survival of P. aeruginosa in infected murine hosts suggests that either drug resistance or host colonization can cause the emergence of more pathogenic, drug-resistant P. aeruginosa clones in a single genetic event.


Footnotes

<SUP>1</SUP>D.S. and D.R. contributed equally to this work.

<SUP>2</SUP>To whom correspondence may be addressed. E-mail: dskurnik@rics.bwh.harvard.edu or gpier@rics.bwh.harvard.edu.

<SUP>3</SUP>V.C. and O.D. contributed equally to this work.

Author contributions: D.S., D.R., V.C., O.D., and G.B.P. designed research; D.S., D.R., V.C., O.D., X.L., D.R.Y.-H., K.H., T.G., D.J., C.G., and F.G. performed research; D.S., D.R., O.D., H.A., R.L., J.J.M., S.L., and G.B.P. analyzed data; and D.S. and G.B.P. wrote the paper.

The authors declare no conflict of interest.

*This Direct Submission article had a prearranged editor.

This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1221552110/-/DCSupplemental.


-
-------
 
Back
Top